Aarti Drugs Ltd.
AARTIDRUGS (NSE)

399.60

3,700.30
Proj. ROE (%)
24.25
Proj. P/E (x)
13.29
Proj EV / EBITDA (x)
8.32
Proj. P/BV (x)
2.77
Proj. Revenue ( Cr.)
2,899.33

Stock View

BUY
Share on
The average score for Aarti Drugs Ltd. stands at 5 against 7, three months back.

Aarti Drugs Limited is an India-based pharmaceutical company engaged in manufacturing active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals. The Company, through its wholly-owned subsidiary Pinnacle Life Science Private Limited, is focused on producing formulations. The Company’s products under APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole and Ofloxacin. Its pharma intermediates products are Tinidazole, Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide and Raloxifene. It also offers specialty chemicals, such as Benzene Sulphonyl Chloride and Methyl Nicotinate. The Company’s products under development include Alcoholism Treatment, Anticoagulant, Antihyperphosphatemia, Anti-cholestrol, Cardiovascular, Cardiprotectant and Antidiabetic.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
421.49
100 DMA ()
447.95
200 DMA ()
502.80
52 Weeks Range
378.00
749.75
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity